Business entry of Indian drug companies alerts local industries.

Published: 2007-07-06 07:00:00

Updated: 2007-07-06 07:00:00

The local pharmaceutical industry keenly alerted to the business entry of the leading Indian pharmaceutical company into Korea, expressing a fear of which local markets might be attacked by far cheaper generic drugs in such a circumstance for the multinational foreign drug corporations to give ev...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK